Healthcare providers’ attitude and knowledge regarding medication use in breastfeeding women: a Jordanian national questionnaire study

2017 ◽  
Vol 38 (2) ◽  
pp. 217-221 ◽  
Author(s):  
Nour A. Al-Sawalha ◽  
Abeer Sawalha ◽  
Linda Tahaineh ◽  
Basima Almomani ◽  
Maha Al-Keilani
Keyword(s):  
Healthcare Providers ◽  
Medication Use ◽  
Questionnaire Study

scholarly journals Preventable adverse drug events causing hospitalisation: identifying root causes and developing a surveillance and learning system at an urban community hospital, a cross-sectional observational study

2021 ◽  
Vol 10 (1) ◽  
pp. e001161
Author(s):  
Jane de Lemos ◽  
Peter Loewen ◽  
Cheryl Nagle ◽  
Robert McKenzie ◽  
Yong Dong You ◽  
...  
Keyword(s):  
Observational Study ◽  
Adverse Drug Events ◽  
Healthcare Providers ◽  
Medication Use ◽  
Learning System ◽  
Chronic Obstructive ◽  
Action Plans ◽  
Medical Conditions ◽  
Cross Sectional ◽  
Medication Changes

ObjectivesTo identify root causes of preventable adverse drug events (pADEs) contributing to hospital admission; to develop key messages which identify actions patients/families and healthcare providers can take to prevent common pADEs found; to develop a surveillance learning system for the community.MethodsCross-sectional observational study; 120 patients and families, 61 associated healthcare providers were interviewed then root cause analysis was performed to develop key learning messages and an electronic reporting tool was designed. Most common pADE-related medical conditions and their root causes and most common pADE root causes of entire cohort are reported.ResultsMost common pADE-related medical conditions: chronic obstructive pulmonary disease/asthma (13.3%), bleeding (12.5%), hypotension (12%), heart failure (10%), acute kidney injury (5%) and pneumonia (5%). Most common root causes were: providers not confirming that the patient/family understands information given (29.2%), can identify how a medication helps them/have their concerns addressed (16.7%), can identify if a medication is working (14.1%) or causing a side effect (23.3%); can enact medication changes (7.5%); absence of a sick day management plan (12.5%), and other action plans to help patients respond to changes in their clinical status (10.8%); providers not assessing medication use and monitoring competency (19.2%). Ten key learning messages were developed and a pADE surveillance learning system was implemented.ConclusionsTo prevent pADEs, providers need to confirm that patients/families understand information given, how a medication helps them, how to recognise and respond to side effects, how to enact medication changes and follow action plans; providers should assess patient’s/families’ medication use and monitoring competency.

scholarly journals PREVALENCE OF OVER THE COUNTER PAIN MEDICATION USE AMONG HIGH SCHOOL VOLLEYBALL PLAYERS

2020 ◽  
Vol 8 (4_suppl3) ◽  
pp. 2325967120S0025
Author(s):  
Pamela Lang ◽  
Timothy McGuine ◽  
Lianna Mack ◽  
Kevin Biese ◽  
David Bell ◽  
...  
Keyword(s):  
High School ◽  
Female Athletes ◽  
Healthcare Providers ◽  
Medication Use ◽  
Pain Medication ◽  
Pain Medicine ◽  
Medicine Use ◽  
Over The Counter ◽  
The Past ◽  
Volleyball Players

Background: Volleyball’s popularity among middle and high school girls continues to rise with many athletes playing the sport year-round. While up to 40% of high school basketball players consume analgesics frequently to manage sport related pain, there is limited evidence regarding the prevalence of over the counter (OTC) pain medicine use among high school volleyball players. Hypothesis/Purpose: Identify the prevalence of OTC pain medicine use in high school volleyball players and assess its association with prior injury and sports specialization level. Methods: Female volleyball players from 78 high schools were recruited to enroll in this prospective cohort study during the fall 2018 volleyball season. Baseline data were collected on demographic and volleyball characteristics including volume and type of volleyball participation, sport-related injuries over the previous twelve months, and level of sport specialization. The frequency of OTC pain medication use for pain management not related to menstrual cramps over the previous seven days was also collected. Participants were asked to describe their OTC pain medicine use during practice, matches, or conditioning and the location of pain they were treating. Results: In total, 2,073 female athletes (Age: 15.6 ± 1.1, BMI: 22.4 ± 3.5, Grade: 9-12) enrolled in the study. Sixty-nine percent (n=1425) reported no OTC pain medication use over the past seven days, 16.0% (n=332) reported seldom (one day/week) OTC medication use, 12.6% (n=261) reported sometimes (2-3 days/week) using OTC medications, and 2.7% (n=55) reported frequent (4-5 days/week) OTC medication use. In the same time period, 24.8% (n=513) used OTC medications during practice, 16.0% (n=331) during matches, and 21.4% (n=443) during conditioning. Across practice, matches, and conditioning OTC medications were most frequently used to control headaches (7-13%) and knee pain (4-6%). Highly specialized volleyball players were more likely to frequently use OTC medications (4.5%) compared to low (1.97%) and moderately specialized (2.5%) athletes (p=0.001). Of those reporting no OTC medications use, 16.7% (n=238) had an injury in the last year compared 36.4% (n=20) of athletes who frequently used OTC medications also reporting an injury in the last year (p<0.001). Conclusion: Almost one third of female high school volleyball athletes reported using OTC pain medications in the past week. Those with a history of injury and highly specialized athletes were more likely to use OTC medications. Coaches, athletic trainers, and healthcare providers should be aware of trends in the use of OTC medications among volleyball athletes as its popularity continues to rise.

scholarly journals Medication non-adherence related to patients’ attitudes and knowledge rather than socio-cultural factors: a study of cardiac clinic attendees at a public healthcare institute

2019 ◽  
Vol 6 (2) ◽  
pp. 480
Author(s):  
Mandreker U. Bahall
Keyword(s):  
Associated Factors ◽  
Healthcare Providers ◽  
Medication Use ◽  
Cross Sectional Study ◽  
Public Healthcare ◽  
Cross Sectional ◽  
Convenience Sample ◽  
Medication Effects ◽  
Data Collection Instrument ◽  
Adherence Data

Background: Medication non-adherence contributes significantly to sub-optimum care, for reasons that could be unique to specific localities. The study sought to identify reasons for non-adherence and associated factors in cardiac clinic attendees at a leading tertiary health institution in Trinidad and Tobago.Methods: This cross-sectional study included a convenience sample of cardiac clinic attendees. The data collection instrument was a questionnaire comprising items regarding socio-demographic characteristics, medical history, social support and reasons for medication non-adherence. Data were collected between March and July, 2016. Non-adherence was identified with total scores of >1 using selected similar questions to that used in the Morisky four-item adherence instrument. Data analyses involved both descriptive and inferential methods.Results: Non-adherent patients represented the largest proportion of participants (n=270, 78.3%). Participants were predominantly women, aged >50 years, of Indo-Trinidadian descent, married, and unemployed. Carelessness (n=251, 93.0%), ceasing medication use when feeling well (n=217, 80.4%), forgetfulness (n=187, 69.3%), and ceasing medication use when feeling worse (n=151, 50.6%) were the leading reasons for non-adherence, followed by unpleasant effects of medication and cost (n=144, 53.3%). Associated factors included feeling that one would become more ill upon ceasing medication use (p=0.003), the importance of understanding the reasons for taking medication (p=0.017), the importance of following physicians’ instructions (p=0.023), and educational level (p=0.040).Conclusions: Effective communication regarding patients’ concerns and potential adverse medication effects between patients and healthcare providers could promote greater adherence.

scholarly journals Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital

2022 ◽  
pp. 089719002110655
Author(s):  
Osama Al-Quteimat ◽  
Mohammad Siddiqui ◽  
Lana Hussein ◽  
Haytham Al Emleh ◽  
Imad EL Dine Shamieh
Keyword(s):  
Clinical Significance ◽  
Tertiary Care ◽  
Healthcare Providers ◽  
Medication Use ◽  
Acceptance Rate ◽  
Adult Patients ◽  
Healthcare Team ◽  
Care Hospital ◽  
Clinical Pharmacists ◽  
Pharmacist Interventions

Background: Pharmacists are integral members of the multidisciplinary healthcare team who, with their skills, knowledge, and training, are well positioned to prevent, identify, and manage medication-related issues. Many published articles related to COVID-19 management have highlighted the important role of the pharmacists in assuring the safe, effective, and cost-effective use of medications. During such challenging times of COVID-19 pandemic that resulted in a high demand on medical resources and healthcare providers, pharmacists are well positioned to contribute and add more efforts to the healthcare system to achieve best use of the available resources including medications and providing high quality pharmaceutical care to help the patients and support the healthcare providers. Methods: This is a retrospective chart review included all admitted adult patients with confirmed COVID-19 diagnosis from 1 March 2020 till 30 June 2020. The documented clinical pharmacist interventions were extracted from the EMR and reviewed by multiple clinical pharmacists to identify type, number, frequency, outcome, and physician’s acceptance rate of documented interventions. Results: A total of 484 pharmacist interventions included in the final analysis. Antimicrobial stewardship interventions were the most reported (149, 30.8%) and antibiotics were the most reported class of medication, constituting 31.1% of the total interventions. “Optimized therapy” was the most commonly reported outcome (58.8%). Overall, 50.8% (246) of the interventions were rated as having “moderate” clinical significance using the clinical significance scoring tool. The physicians’ acceptance rate was 94.7%. Conclusion: Pharmacist interventions are associated with improved communication and medication use in admitted adult patients with COVID-19. Clinical pharmacists can play a crucial role in optimizing medication use in patients with COVID-19 through prevention, identification, and resolving existing or potential drug-related problems.

scholarly journals Medication Use During Pregnancy and Lactation in a Dutch Population

2018 ◽  
Vol 35 (1) ◽  
pp. 154-164 ◽  
Author(s):  
Marita de Waard ◽  
Birgit S. Blomjous ◽  
Marinka L. F. Hol ◽  
Sintha D. Sie ◽  
Willemijn E. Corpeleijn ◽  
...  
Keyword(s):  
Healthcare Providers ◽  
Medication Use ◽  
Information Service ◽  
Structured Interview ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Lactating Women ◽  
Unknown Risk ◽  
Tertiary Center ◽  
Pregnancy And Lactation

Background: Medication use during pregnancy and lactation can be unavoidable, but knowledge on safety for the fetus or breastfed infant is limited among patients and healthcare providers. Research aim: This study aimed to determine (a) the prevalence of medication use in pregnant and lactating women in a tertiary academic center, (b) the types and safety of these medicines, and (c) the influence of medication use on initiation of breastfeeding. Methods: This study used a cross-sectional survey among women ( N = 292) who underwent high-risk or low-risk deliveries. Data about their use of prescribed, over-the-counter, and homeopathic medication during pregnancy were obtained through a structured interview, followed by a questionnaire during lactation. Safety was classified according to the risk classification system from the Dutch Teratological Information Service. Results: Overall, 95.5% of participants used medication. One third of participants used at least one medicine with an unknown risk for the fetus. Teratogenic medication was used by 6.5% of participants, whereas 29.5% used medication with a (suspected) pharmacological effect on the fetus. Lactation was initiated by 258 (88.7%) participants, of which 84.2% used medication while breastfeeding. In 3.8% of participants, this medication was classified unsafe, but none used medication with an unknown risk. One-third of the nonlactating participants decided not to initiate breastfeeding because of medication use. In 70% of participants, this decision was appropriate. Conclusion: The prevalence of overall use of medication in Dutch pregnant and lactating women admitted to a tertiary center was high. There is an urgent need for pharmacometric studies for determination of the safe use of the most frequently used medicines during pregnancy or lactation.

Sign in / Sign up

Export Citation Format

Share Document